Insight Molecular (IMDX): Market Cap to Revenue Ratio

Symbol and logo of brand Insight Molecular (IMDX)

The investment potential of Insight Molecular Diagnostics (IMDX) is based on the supply of early cancer detection systems to clinics. The price-to-sales ratio visualizes market expectations, where the 44.70 level indicates the status of the parameter. Strong pricing power is driven by the uniqueness of the molecular tests. Risks associated with narrow specialization are mitigated by patents and the global trend toward preventive oncodiagnostics.

Insight Molecular (IMDX): P/S Multiple from 06/19/2025 to 11/13/2026

Analytical breakdowns for Insight Molecular Diagnostics (IMDX)

- price and consensus price forecast:
Market Chart imdxinc.com|IMDX - Price Target Chart
- stock exchange capitalization data:
Market Capitalization Insight Molecular|IMDX - Total Company Value
- business book valuation details:
Net Assets per Share Insight Molecular Diagnostics|IMDX - Book Capitalization|Market Capitalization to Book Value imdxinc.com|IMDX - Company Total Assets
- issuer credit burden and liquidity indicators:
Debt to Capital Ratio Insight Molecular Diagnostics|IMDX - Long-Term Debt to Capital|Ratio of Short-Term Indebtedness to Capital imdxinc.com|IMDX - Company Total Debt|Debt to Book Capital Insight Molecular|IMDX - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Insight Molecular Diagnostics|Quick Liquidity Indicator imdxinc.com
- net income and valuation ratios data:
IMDX - Company Net Income|Expected Net Profit Insight Molecular Diagnostics|IMDX - Price to Earnings Ratio|Future Price to Earnings imdxinc.com|IMDX - PEG Multiple|Company Value to EBITDA Insight Molecular|IMDX - Operating profit EBITDA|Net earnings per share for the last 12 months Insight Molecular Diagnostics|IMDX - Net earnings per share for the last 12 months|Quarterly EPS earnings growth imdxinc.com|IMDX - Earnings per share growth in current year|Net earnings per share growth forecast for next year Insight Molecular Diagnostics
- issuer revenue and sales details:
IMDX - Revenue and Sales Volume|Projected Sales Volume imdxinc.com|IMDX - Price-to-Revenue Ratio|Forward Price to Sales Insight Molecular
Summary company analytics:Insight Molecular Diagnostics, Inc.
Manufactured product of Insight Molecular Diagnostics Inc

The P/S ratio is utilized to assess the market value of Insight Molecular Diagnostics (IMDX) within the high-tech diagnostics sector. The current P/S level reflects the ratio of market capitalization to annual revenue, indicating how much investors are willing to pay per unit of sales. This metric allows for a comparison between speculative demand and actual revenue generated from robotic DNA analyses. The fundamental stability of the business depends on the balance between AI automation and the demand for expert medical interpretation.

Who Insight Molecular Diagnostics competes with

Price-to-Revenue Coefficient agilent.com|Price-to-Revenue Ratio Quest Diagnostics Incorporated DGX|ILMN: Market Cap to Revenue Ratio|EXAS - Price-to-Revenue Ratio|Price-to-Revenue Coefficient Revvity Corp RVTY|BIO: P/S Multiple|NNNN - Price-to-Revenue Coefficient|SHC (Sotera Health) - P/S Multiple|QDEL - Price-to-Revenue Multiple|P/S Multiple OPK|CDNA (CareDx Health) - Market Capitalization-to-Revenue Ratio|Maravai LifeSciences - Market Cap to Revenue|Market Cap to Sales Volume FLGT (fulgentgenetics.com)|LAB: Market Cap to Revenue|Market Capitalization-to-Revenue Ratio CTKB (Cytek Biosciences Inc)|OraSure Technologies Inc (OSUR) - Price-to-Revenue Ratio|Market Cap to Revenue Exagen|Price-to-Revenue Ratio MDxHealth SA|Price to Sales luciddx.com LUCD|Price-to-Revenue Ratio Prenetics Global (PRE)|Price-to-Revenue Ratio TRIB (trinitybiotech.com)|P/S Multiple PRPH (ProPhase)|Ainos Corporation (AIMD) - Price to Sales|Co-Diagnostics, Inc. - P/S Multiple|heartsciences.com (HSCS) - Market Cap to Revenue|BMRA (Biomerica) - Market Cap to Revenue|Cardio Diagnostics Holdings (CDIO) - P/S Multiple|Price-to-Revenue Ratio Onconetix Corp|Price-to-Revenue Ratio VRAX|P/S Multiple BJDX|P/S Multiple aspirawh.com (AWH)|Price-to-Revenue Ratio Accelerate Diagnostics, Inc. AXDX|Market Capitalization-to-Revenue Ratio CNTG|ENZ: Market Cap to Revenue|Market Capitalization-to-Revenue Ratio FRES (Fresh2 Group Limited)|GENE: P/S Multiple|Market Cap to Revenue Ratio ME|PMD (Psychemedics Corporation) - P/S Multiple